APO Research
Talk to an analyst

APO RESEARCH · REPORT

Arthritis Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Arthritis Drug Market Analysis and Forecast 2026-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchArthritis Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Arthritis Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Arthritis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arthritis Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Arthritis Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Arthritis Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Arthritis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Arthritis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Arthritis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Arthritis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Arthritis Drug include Celltrion, F. Hoffmann-La Roche, GSK, Pfizer, Eli Lilly, Novartis and Johnson & Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Arthritis Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Arthritis Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Arthritis Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Arthritis Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Arthritis Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Arthritis Drug sales, projected growth trends, production technology, application and end-user industry.

Arthritis Drug Segment by Company

Celltrion

F. Hoffmann-La Roche

GSK

Pfizer

Eli Lilly

Novartis

Johnson & Johnson

Arthritis Drug Segment by Type

Analgesics

Biological DMARDs

Corticosteroids

Synthetic DMARDs

NSAIDs

Arthritis Drug Segment by Application

Hospital Pharmacies

Drug Stores

Retail Pharmacies

E-Commerce

Arthritis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arthritis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arthritis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arthritis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Arthritis Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Arthritis Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Arthritis Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Arthritis Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Analgesics Major Manufacturers Table 3. Biological DMARDs Major Manufacturers Table 4. Corticosteroids Major Manufacturers Table 5. Synthetic DMARDs Major Manufacturers Table 6. NSAIDs Major Manufacturers Table 7. Global Arthritis Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Pharmacies Major Manufacturers Table 9. Drug Stores Major Manufacturers Table 10. Retail Pharmacies Major Manufacturers Table 11. E-Commerce Major Manufacturers Table 12. Arthritis Drug Industry Trends Table 13. Arthritis Drug Industry Drivers Table 14. Arthritis Drug Industry Opportunities and Challenges Table 15. Arthritis Drug Industry Restraints Table 16. Global Arthritis Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Arthritis Drug Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Arthritis Drug Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Arthritis Drug Revenue Market Share by Region (2021-2026) Table 20. Global Arthritis Drug Revenue Market Share by Region (2027-2032) Table 21. Global Arthritis Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Arthritis Drug Sales by Region (2021-2026) & (k units) Table 23. Global Arthritis Drug Sales by Region (2027-2032) & (k units) Table 24. Global Arthritis Drug Sales Market Share by Region (2021-2026) Table 25. Global Arthritis Drug Sales Market Share by Region (2027-2032) Table 26. Global Arthritis Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Arthritis Drug Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Arthritis Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Arthritis Drug Sales Market Share by Manufacturers (2021-2026) Table 30. Global Arthritis Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Arthritis Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Arthritis Drug Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Arthritis Drug Manufacturers, Product Type & Application Table 34. Global Arthritis Drug Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Arthritis Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Arthritis Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Arthritis Drug Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Arthritis Drug Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Arthritis Drug Revenue Market Share by Type (2021-2026) Table 41. Global Arthritis Drug Revenue Market Share by Type (2027-2032) Table 42. Global Arthritis Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Arthritis Drug Sales by Type (2021-2026) & (k units) Table 44. Global Arthritis Drug Sales by Type (2027-2032) & (k units) Table 45. Global Arthritis Drug Sales Market Share by Type (2021-2026) Table 46. Global Arthritis Drug Sales Market Share by Type (2027-2032) Table 47. Global Arthritis Drug Price by Type (2021-2026) & (US$/unit) Table 48. Global Arthritis Drug Price by Type (2027-2032) & (US$/unit) Table 49. Global Arthritis Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Arthritis Drug Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Arthritis Drug Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Arthritis Drug Revenue Market Share by Application (2021-2026) Table 53. Global Arthritis Drug Revenue Market Share by Application (2027-2032) Table 54. Global Arthritis Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Arthritis Drug Sales by Application (2021-2026) & (k units) Table 56. Global Arthritis Drug Sales by Application (2027-2032) & (k units) Table 57. Global Arthritis Drug Sales Market Share by Application (2021-2026) Table 58. Global Arthritis Drug Sales Market Share by Application (2027-2032) Table 59. Global Arthritis Drug Price by Application (2021-2026) & (US$/unit) Table 60. Global Arthritis Drug Price by Application (2027-2032) & (US$/unit) Table 61. Celltrion Company Information Table 62. Celltrion Business Overview Table 63. Celltrion Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Celltrion Arthritis Drug Product Portfolio Table 65. Celltrion Recent Development Table 66. F. Hoffmann-La Roche Company Information Table 67. F. Hoffmann-La Roche Business Overview Table 68. F. Hoffmann-La Roche Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. F. Hoffmann-La Roche Arthritis Drug Product Portfolio Table 70. F. Hoffmann-La Roche Recent Development Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. GSK Arthritis Drug Product Portfolio Table 75. GSK Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Pfizer Arthritis Drug Product Portfolio Table 80. Pfizer Recent Development Table 81. Eli Lilly Company Information Table 82. Eli Lilly Business Overview Table 83. Eli Lilly Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Eli Lilly Arthritis Drug Product Portfolio Table 85. Eli Lilly Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Novartis Arthritis Drug Product Portfolio Table 90. Novartis Recent Development Table 91. Johnson & Johnson Company Information Table 92. Johnson & Johnson Business Overview Table 93. Johnson & Johnson Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Johnson & Johnson Arthritis Drug Product Portfolio Table 95. Johnson & Johnson Recent Development Table 96. North America Arthritis Drug Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Arthritis Drug Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Arthritis Drug Sales by Type (2021-2026) & (k units) Table 99. North America Arthritis Drug Sales by Type (2027-2032) & (k units) Table 100. North America Arthritis Drug Sales Price by Type (2021-2026) & (US$/unit) Table 101. North America Arthritis Drug Sales Price by Type (2027-2032) & (US$/unit) Table 102. North America Arthritis Drug Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Arthritis Drug Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Arthritis Drug Sales by Application (2021-2026) & (k units) Table 105. North America Arthritis Drug Sales by Application (2027-2032) & (k units) Table 106. North America Arthritis Drug Sales Price by Application (2021-2026) & (US$/unit) Table 107. North America Arthritis Drug Sales Price by Application (2027-2032) & (US$/unit) Table 108. North America Arthritis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Arthritis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 110. North America Arthritis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 111. North America Arthritis Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 112. North America Arthritis Drug Sales by Country (2021-2026) & (k units) Table 113. North America Arthritis Drug Sales by Country (2027-2032) & (k units) Table 114. North America Arthritis Drug Sales Price by Country (2021-2026) & (US$/unit) Table 115. North America Arthritis Drug Sales Price by Country (2027-2032) & (US$/unit) Table 116. United States Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 117. Canada Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 118. Mexico Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 119. Europe Arthritis Drug Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Arthritis Drug Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Arthritis Drug Sales by Type (2021-2026) & (k units) Table 122. Europe Arthritis Drug Sales by Type (2027-2032) & (k units) Table 123. Europe Arthritis Drug Sales Price by Type (2021-2026) & (US$/unit) Table 124. Europe Arthritis Drug Sales Price by Type (2027-2032) & (US$/unit) Table 125. Europe Arthritis Drug Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Arthritis Drug Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Arthritis Drug Sales by Application (2021-2026) & (k units) Table 128. Europe Arthritis Drug Sales by Application (2027-2032) & (k units) Table 129. Europe Arthritis Drug Sales Price by Application (2021-2026) & (US$/unit) Table 130. Europe Arthritis Drug Sales Price by Application (2027-2032) & (US$/unit) Table 131. Europe Arthritis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Arthritis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. Europe Arthritis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. Europe Arthritis Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 135. Europe Arthritis Drug Sales by Country (2021-2026) & (k units) Table 136. Europe Arthritis Drug Sales by Country (2027-2032) & (k units) Table 137. Europe Arthritis Drug Sales Price by Country (2021-2026) & (US$/unit) Table 138. Europe Arthritis Drug Sales Price by Country (2027-2032) & (US$/unit) Table 139. Germany Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 140. France Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 141. U.K. Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 142. Italy Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 143. Russia Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 144. Spain Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 145. Netherlands Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 146. Switzerland Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 147. Sweden Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 148. Poland Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 149. China Arthritis Drug Revenue by Type (2021-2026) & (US$ Million) Table 150. China Arthritis Drug Revenue by Type (2027-2032) & (US$ Million) Table 151. China Arthritis Drug Sales by Type (2021-2026) & (k units) Table 152. China Arthritis Drug Sales by Type (2027-2032) & (k units) Table 153. China Arthritis Drug Sales Price by Type (2021-2026) & (US$/unit) Table 154. China Arthritis Drug Sales Price by Type (2027-2032) & (US$/unit) Table 155. China Arthritis Drug Revenue by Application (2021-2026) & (US$ Million) Table 156. China Arthritis Drug Revenue by Application (2027-2032) & (US$ Million) Table 157. China Arthritis Drug Sales by Application (2021-2026) & (k units) Table 158. China Arthritis Drug Sales by Application (2027-2032) & (k units) Table 159. China Arthritis Drug Sales Price by Application (2021-2026) & (US$/unit) Table 160. China Arthritis Drug Sales Price by Application (2027-2032) & (US$/unit) Table 161. Asia Arthritis Drug Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Arthritis Drug Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Arthritis Drug Sales by Type (2021-2026) & (k units) Table 164. Asia Arthritis Drug Sales by Type (2027-2032) & (k units) Table 165. Asia Arthritis Drug Sales Price by Type (2021-2026) & (US$/unit) Table 166. Asia Arthritis Drug Sales Price by Type (2027-2032) & (US$/unit) Table 167. Asia Arthritis Drug Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Arthritis Drug Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Arthritis Drug Sales by Application (2021-2026) & (k units) Table 170. Asia Arthritis Drug Sales by Application (2027-2032) & (k units) Table 171. Asia Arthritis Drug Sales Price by Application (2021-2026) & (US$/unit) Table 172. Asia Arthritis Drug Sales Price by Application (2027-2032) & (US$/unit) Table 173. Asia Arthritis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Arthritis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia Arthritis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia Arthritis Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 177. Asia Arthritis Drug Sales by Country (2021-2026) & (k units) Table 178. Asia Arthritis Drug Sales by Country (2027-2032) & (k units) Table 179. Asia Arthritis Drug Sales Price by Country (2021-2026) & (US$/unit) Table 180. Asia Arthritis Drug Sales Price by Country (2027-2032) & (US$/unit) Table 181. Japan Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 182. South Korea Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 183. India Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 184. Australia Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 185. Taiwan Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 187. SAMEA Arthritis Drug Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA Arthritis Drug Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA Arthritis Drug Sales by Type (2021-2026) & (k units) Table 190. SAMEA Arthritis Drug Sales by Type (2027-2032) & (k units) Table 191. SAMEA Arthritis Drug Sales Price by Type (2021-2026) & (US$/unit) Table 192. SAMEA Arthritis Drug Sales Price by Type (2027-2032) & (US$/unit) Table 193. SAMEA Arthritis Drug Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA Arthritis Drug Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA Arthritis Drug Sales by Application (2021-2026) & (k units) Table 196. SAMEA Arthritis Drug Sales by Application (2027-2032) & (k units) Table 197. SAMEA Arthritis Drug Sales Price by Application (2021-2026) & (US$/unit) Table 198. SAMEA Arthritis Drug Sales Price by Application (2027-2032) & (US$/unit) Table 199. SAMEA Arthritis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA Arthritis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA Arthritis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA Arthritis Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 203. SAMEA Arthritis Drug Sales by Country (2021-2026) & (k units) Table 204. SAMEA Arthritis Drug Sales by Country (2027-2032) & (k units) Table 205. SAMEA Arthritis Drug Sales Price by Country (2021-2026) & (US$/unit) Table 206. SAMEA Arthritis Drug Sales Price by Country (2027-2032) & (US$/unit) Table 207. Brazil Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 208. Argentina Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 209. Chile Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 210. Colombia Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 211. Peru Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 213. Israel Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 214. UAE Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 215. Turkey Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 216. Iran Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 217. Egypt Arthritis Drug Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. Arthritis Drug Distributors List Table 221. Arthritis Drug Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Arthritis Drug Image Figure 2. Global Arthritis Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arthritis Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Analgesics Image Figure 5. Biological DMARDs Image Figure 6. Corticosteroids Image Figure 7. Synthetic DMARDs Image Figure 8. NSAIDs Image Figure 9. Global Arthritis Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Arthritis Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Pharmacies Image Figure 12. Drug Stores Image Figure 13. Retail Pharmacies Image Figure 14. E-Commerce Image Figure 15. Global Arthritis Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Arthritis Drug Revenue (2021-2032) & (US$ Million) Figure 17. Global Arthritis Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Arthritis Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Arthritis Drug Revenue Market Share by Region (2021-2032) Figure 20. Global Arthritis Drug Sales (2021-2032) & (k units) Figure 21. Global Arthritis Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Arthritis Drug Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Arthritis Drug Sales YoY (2021-2032) & (k units) Figure 24. Europe Arthritis Drug Sales YoY (2021-2032) & (k units) Figure 25. China Arthritis Drug Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Arthritis Drug Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Arthritis Drug Sales YoY (2021-2032) & (k units) Figure 28. Global Arthritis Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Arthritis Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Arthritis Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Arthritis Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Arthritis Drug Revenue Market Share by Type (2021-2032) Figure 34. Global Arthritis Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Arthritis Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Arthritis Drug Sales Market Share by Type (2021-2032) Figure 37. Global Arthritis Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Arthritis Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Arthritis Drug Revenue Market Share by Application (2021-2032) Figure 40. Global Arthritis Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Arthritis Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Arthritis Drug Sales Market Share by Application (2021-2032) Figure 43. North America Arthritis Drug Revenue Share by Type (2021-2032) Figure 44. North America Arthritis Drug Sales Share by Type (2021-2032) Figure 45. North America Arthritis Drug Revenue Share by Application (2021-2032) Figure 46. North America Arthritis Drug Sales Share by Application (2021-2032) Figure 47. North America Arthritis Drug Revenue Share by Country (2021-2032) Figure 48. North America Arthritis Drug Sales Share by Country (2021-2032) Figure 49. Europe Arthritis Drug Revenue Share by Type (2021-2032) Figure 50. Europe Arthritis Drug Sales Share by Type (2021-2032) Figure 51. Europe Arthritis Drug Revenue Share by Application (2021-2032) Figure 52. Europe Arthritis Drug Sales Share by Application (2021-2032) Figure 53. Europe Arthritis Drug Revenue Share by Country (2021-2032) Figure 54. Europe Arthritis Drug Sales Share by Country (2021-2032) Figure 55. China Arthritis Drug Revenue Share by Type (2021-2032) Figure 56. China Arthritis Drug Sales Share by Type (2021-2032) Figure 57. China Arthritis Drug Revenue Share by Application (2021-2032) Figure 58. China Arthritis Drug Sales Share by Application (2021-2032) Figure 59. Asia Arthritis Drug Revenue Share by Type (2021-2032) Figure 60. Asia Arthritis Drug Sales Share by Type (2021-2032) Figure 61. Asia Arthritis Drug Revenue Share by Application (2021-2032) Figure 62. Asia Arthritis Drug Sales Share by Application (2021-2032) Figure 63. Asia Arthritis Drug Revenue Share by Country (2021-2032) Figure 64. Asia Arthritis Drug Sales Share by Country (2021-2032) Figure 65. SAMEA Arthritis Drug Revenue Share by Type (2021-2032) Figure 66. SAMEA Arthritis Drug Sales Share by Type (2021-2032) Figure 67. SAMEA Arthritis Drug Revenue Share by Application (2021-2032) Figure 68. SAMEA Arthritis Drug Sales Share by Application (2021-2032) Figure 69. SAMEA Arthritis Drug Revenue Share by Country (2021-2032) Figure 70. SAMEA Arthritis Drug Sales Share by Country (2021-2032) Figure 71. Arthritis Drug Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Arthritis Drug Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Biological DMARDs
  • Corticosteroids
  • Synthetic DMARDs
  • NSAIDs
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • E-Commerce
Companies covered
  • Celltrion
  • F. Hoffmann-La Roche
  • GSK
  • Pfizer
  • Eli Lilly
  • Novartis
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Arthritis Drug Market by Type
  3. 1.2.1 Global Arthritis Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Analgesics
  5. 1.2.3 Biological DMARDs
  6. 1.2.4 Corticosteroids
  7. 1.2.5 Synthetic DMARDs
  8. 1.2.6 NSAIDs
  9. 1.3 Arthritis Drug Market by Application
  10. 1.3.1 Global Arthritis Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital Pharmacies
  12. 1.3.3 Drug Stores
  13. 1.3.4 Retail Pharmacies
  14. 1.3.5 E-Commerce
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Arthritis Drug Market Dynamics
  1. 2.1 Arthritis Drug Industry Trends
  2. 2.2 Arthritis Drug Industry Drivers
  3. 2.3 Arthritis Drug Industry Opportunities and Challenges
  4. 2.4 Arthritis Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Arthritis Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Arthritis Drug Revenue by Region
  3. 3.2.1 Global Arthritis Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Arthritis Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Arthritis Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Arthritis Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Arthritis Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Arthritis Drug Sales by Region
  9. 3.4.1 Global Arthritis Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Arthritis Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Arthritis Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Arthritis Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Arthritis Drug Revenue by Manufacturers
  2. 4.1.1 Global Arthritis Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Arthritis Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Arthritis Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Arthritis Drug Sales by Manufacturers
  6. 4.2.1 Global Arthritis Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Arthritis Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Arthritis Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Arthritis Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Arthritis Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Arthritis Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Arthritis Drug Manufacturers, Product Type & Application
  13. 4.7 Global Arthritis Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Arthritis Drug Market CR5 and HHI
  16. 4.8.2 2025 Arthritis Drug Tier 1, Tier 2, and Tier 3
5 Arthritis Drug Market by Type
  1. 5.1 Global Arthritis Drug Revenue by Type
  2. 5.1.1 Global Arthritis Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Arthritis Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Arthritis Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Arthritis Drug Sales by Type
  6. 5.2.1 Global Arthritis Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Arthritis Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Arthritis Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Arthritis Drug Price by Type
6 Arthritis Drug Market by Application
  1. 6.1 Global Arthritis Drug Revenue by Application
  2. 6.1.1 Global Arthritis Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Arthritis Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Arthritis Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Arthritis Drug Sales by Application
  6. 6.2.1 Global Arthritis Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Arthritis Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Arthritis Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Arthritis Drug Price by Application
7 Company Profiles
  1. 7.1 Celltrion
  2. 7.1.1 Celltrion Company Information
  3. 7.1.2 Celltrion Business Overview
  4. 7.1.3 Celltrion Arthritis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Celltrion Arthritis Drug Product Portfolio
  6. 7.1.5 Celltrion Recent Developments
  7. 7.2 F. Hoffmann-La Roche
  8. 7.2.1 F. Hoffmann-La Roche Company Information
  9. 7.2.2 F. Hoffmann-La Roche Business Overview
  10. 7.2.3 F. Hoffmann-La Roche Arthritis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 F. Hoffmann-La Roche Arthritis Drug Product Portfolio
  12. 7.2.5 F. Hoffmann-La Roche Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Arthritis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GSK Arthritis Drug Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Arthritis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Arthritis Drug Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 Eli Lilly
  26. 7.5.1 Eli Lilly Company Information
  27. 7.5.2 Eli Lilly Business Overview
  28. 7.5.3 Eli Lilly Arthritis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Eli Lilly Arthritis Drug Product Portfolio
  30. 7.5.5 Eli Lilly Recent Developments
  31. 7.6 Novartis
  32. 7.6.1 Novartis Company Information
  33. 7.6.2 Novartis Business Overview
  34. 7.6.3 Novartis Arthritis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novartis Arthritis Drug Product Portfolio
  36. 7.6.5 Novartis Recent Developments
  37. 7.7 Johnson & Johnson
  38. 7.7.1 Johnson & Johnson Company Information
  39. 7.7.2 Johnson & Johnson Business Overview
  40. 7.7.3 Johnson & Johnson Arthritis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Johnson & Johnson Arthritis Drug Product Portfolio
  42. 7.7.5 Johnson & Johnson Recent Developments
8 North America
  1. 8.1 North America Arthritis Drug Market Size by Type
  2. 8.1.1 North America Arthritis Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Arthritis Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Arthritis Drug Price by Type (2021-2032)
  5. 8.2 North America Arthritis Drug Market Size by Application
  6. 8.2.1 North America Arthritis Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Arthritis Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Arthritis Drug Price by Application (2021-2032)
  9. 8.3 North America Arthritis Drug Market Size by Country
  10. 8.3.1 North America Arthritis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Arthritis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Arthritis Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Arthritis Drug Market Size by Type
  2. 9.1.1 Europe Arthritis Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Arthritis Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Arthritis Drug Price by Type (2021-2032)
  5. 9.2 Europe Arthritis Drug Market Size by Application
  6. 9.2.1 Europe Arthritis Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Arthritis Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Arthritis Drug Price by Application (2021-2032)
  9. 9.3 Europe Arthritis Drug Market Size by Country
  10. 9.3.1 Europe Arthritis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Arthritis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Arthritis Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Arthritis Drug Market Size by Type
  2. 10.1.1 China Arthritis Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Arthritis Drug Sales by Type (2021-2032)
  4. 10.1.3 China Arthritis Drug Price by Type (2021-2032)
  5. 10.2 China Arthritis Drug Market Size by Application
  6. 10.2.1 China Arthritis Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Arthritis Drug Sales by Application (2021-2032)
  8. 10.2.3 China Arthritis Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Arthritis Drug Market Size by Type
  2. 11.1.1 Asia Arthritis Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Arthritis Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Arthritis Drug Price by Type (2021-2032)
  5. 11.2 Asia Arthritis Drug Market Size by Application
  6. 11.2.1 Asia Arthritis Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Arthritis Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Arthritis Drug Price by Application (2021-2032)
  9. 11.3 Asia Arthritis Drug Market Size by Country
  10. 11.3.1 Asia Arthritis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Arthritis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Arthritis Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Arthritis Drug Market Size by Type
  2. 12.1.1 SAMEA Arthritis Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Arthritis Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Arthritis Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Arthritis Drug Market Size by Application
  6. 12.2.1 SAMEA Arthritis Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Arthritis Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Arthritis Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Arthritis Drug Market Size by Country
  10. 12.3.1 SAMEA Arthritis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Arthritis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Arthritis Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Arthritis Drug Value Chain Analysis
  2. 13.1.1 Arthritis Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Arthritis Drug Production Mode & Process
  6. 13.2 Arthritis Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Arthritis Drug Distributors
  9. 13.2.3 Arthritis Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst